Speaker
Description
Background/Aim: As tattooing becomes increasingly popular worldwide, its potential contribution to blood-borne viral infections remains a public health concern. Hepatitis B (HBV) and C (HCV) infections are major causes of liver cancer. We aimed to quantify the associations between tattooing and HBV/HCV infection globally and examine their consistency across populations and geographical settings.
Methods: We systematically searched PubMed, Embase, and Web of Science through October 2025. Observational studies reporting laboratory-confirmed HBV/HCV infection were included. Adjusted odds ratios (ORs) were pooled using random-effects meta-analysis, with subgroup and sensitivity analyses assessing geographical variation and potential confounding.
Results: We included 238 publications representing 240 independent study samples and 591,527 participants across all six WHO regions. Tattooing was associated with more than twice the odds of HBV infection (adjusted OR 2.30, 95% CI 1.85–2.86) and three times the odds of HCV infection (3.03, 2.70–3.40). Associations persisted in analyses accounting for injecting drug use and sexual risk behaviours. Significant geographical variation was observed, highlighting the importance of epidemiological context.
Conclusion: This comprehensive global synthesis identifies tattooing as an important correlate of HBV/HCV infection, with implications for liver cancer prevention. Findings support strengthened infection prevention during tattooing and further evaluation of tattoo history and circumstances in risk-based hepatitis testing strategies.